CA2983992A1 - Polycyclic indoline and indolenine compounds - Google Patents

Polycyclic indoline and indolenine compounds

Info

Publication number
CA2983992A1
CA2983992A1 CA2983992A CA2983992A CA2983992A1 CA 2983992 A1 CA2983992 A1 CA 2983992A1 CA 2983992 A CA2983992 A CA 2983992A CA 2983992 A CA2983992 A CA 2983992A CA 2983992 A1 CA2983992 A1 CA 2983992A1
Authority
CA
Canada
Prior art keywords
compound
alkyl
group
formula
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2983992A
Other languages
English (en)
French (fr)
Inventor
Xiang Wang
Patrick BARBOUR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado Colorado Springs
Original Assignee
University of Colorado Colorado Springs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado Colorado Springs filed Critical University of Colorado Colorado Springs
Publication of CA2983992A1 publication Critical patent/CA2983992A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA2983992A 2015-04-30 2016-04-29 Polycyclic indoline and indolenine compounds Abandoned CA2983992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562154792P 2015-04-30 2015-04-30
US62/154,792 2015-04-30
PCT/US2016/030233 WO2016176634A1 (en) 2015-04-30 2016-04-29 Polycyclic indoline and indolenine compounds

Publications (1)

Publication Number Publication Date
CA2983992A1 true CA2983992A1 (en) 2016-11-03

Family

ID=57199452

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2983992A Abandoned CA2983992A1 (en) 2015-04-30 2016-04-29 Polycyclic indoline and indolenine compounds

Country Status (6)

Country Link
US (1) US10253024B2 (https=)
EP (1) EP3288921B1 (https=)
JP (1) JP6917901B2 (https=)
CN (1) CN107922334B (https=)
CA (1) CA2983992A1 (https=)
WO (1) WO2016176634A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6845511B2 (ja) * 2015-07-09 2021-03-17 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 抗細菌性薬剤併用物の組成物及び使用方法
US10292972B1 (en) * 2017-10-26 2019-05-21 King Abdulaziz University Pharmaceutical composition for treating cancer and a method thereof
CN108864107B (zh) * 2018-08-01 2020-09-08 南通睿沣新材料技术有限公司 一种具有抑菌作用的吲哚类化合物的制备方法
CN117924299B (zh) * 2023-12-05 2024-08-16 贵州省天然产物研究中心 多并环吡咯[2,3-b]吲哚啉类化合物及其制备方法和应用以及药物组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155587A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 7-chlorotetracycline
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3847770A (en) 1972-04-10 1974-11-12 Continental Can Co Photopolymerizable compositions prepared from beta hydroxy esters and polyitaconates
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4769027A (en) 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4687610A (en) 1986-04-30 1987-08-18 E. I. Du Pont De Neumours And Company Low crystallinity polyester yarn produced at ultra high spinning speeds
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5354566A (en) 1993-06-02 1994-10-11 Kraft General Foods, Inc. Preparation of yeast-leavened dough crusts
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
KR102107954B1 (ko) * 2007-03-12 2020-05-07 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
WO2011103460A1 (en) * 2010-02-18 2011-08-25 Medivation Technologies, Inc. Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
US9745266B2 (en) 2013-04-01 2017-08-29 The Regents Of The University Of Colorado Indoline alkaloid compounds

Also Published As

Publication number Publication date
US20180148442A1 (en) 2018-05-31
US10253024B2 (en) 2019-04-09
CN107922334B (zh) 2021-11-23
JP6917901B2 (ja) 2021-08-11
JP2018515466A (ja) 2018-06-14
WO2016176634A1 (en) 2016-11-03
EP3288921A1 (en) 2018-03-07
EP3288921B1 (en) 2022-06-15
CN107922334A (zh) 2018-04-17
EP3288921A4 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
JP2023521698A (ja) Ｋｒａｓの標的化分解のための化合物及び方法
CA2829939C (en) Tricyclic gyrase inhibitors
RU2350604C2 (ru) Производные тетрагидрохинолина, демонстрирующие защитное от вич-инфекции действие
CN109641918B (zh) 作为组蛋白去甲基化酶抑制剂的咪唑
EP3233835A1 (en) Benzazepine sulfonamide compounds
ES2618891T3 (es) N,N'-diariltioureas y N,N¿-diarilureas cíclicas como antagonistas del receptor de andrógenos, agente anticanceroso, método para producirlo y usarlo
TW200916447A (en) Sirtuin inhibitors
JP2012530703A (ja) 置換ヒドロキサム酸およびその使用
CA2885828C (en) Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death
CN107835810A (zh) 作为hdac1/2抑制剂的哌啶衍生物
JP2000204084A (ja) チオカルバミド酸誘導体
KR20220130697A (ko) 새로운 화합물 및 그 용도
EP3288921B1 (en) Polycyclic indoline and indolenine compounds
WO2017198221A1 (zh) 嘧啶类衍生物、其制备方法和其在医药上的用途
US20190152943A1 (en) Tetrahydroindazoles and medical uses thereof
JP2022502497A (ja) Ｈｄａｃ１、２の阻害剤
US7244847B2 (en) Benzimidazole compounds
WO2020027723A1 (en) Bicyclic compounds as kinase modulators, methods and uses thereof
KR20250159187A (ko) Cdk12/13에 대한 아릴 치환기 함유 분해제, 이의 제조 방법, 및 이의 약제학적 조성물과 용도
KR20010042482A (ko) Ｍｒｐ1의 억제 방법
WO2013148631A1 (en) Cyclic prodrugs of duocarmycin analogs
KR101420613B1 (ko) 신규한 스트렙토클로린 유도체 및 이를 유효성분으로 하는 암 질환의 예방 및 치료용 약학조성물
TW201629019A (zh) ３，５－二胺基吡唑激酶抑制劑
KR101725292B1 (ko) 항암 활성을 갖는 신규 피리미딘-4-카르복시산 유도체
CA2416036A1 (en) Substituted amidoalkyl-uracils as parp inhibitors

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210301

FZDE Discontinued

Effective date: 20221031